Krystal Biotech, Inc. KRYS Common stock, shares issued (in shares)
Common stock, shares issued (in shares) at other companies
Other financials
Where this comes from
Reported directly by Krystal Biotech, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CommonStockSharesIssued.
The official record: Krystal Biotech, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Krystal Biotech, Inc.'s common stock, shares issued (in shares).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Krystal Biotech, Inc.'s common stock, shares issued (in shares)?
- Krystal Biotech, Inc. (KRYS) reported common stock, shares issued (in shares) of $29.44M in Q1 2026.
- How has Krystal Biotech, Inc.'s common stock, shares issued (in shares) changed year-over-year?
- Krystal Biotech, Inc.'s common stock, shares issued (in shares) increased by 1.9% year-over-year, from $28.9M to $29.44M.
- What is the long-term trend for Krystal Biotech, Inc.'s common stock, shares issued (in shares)?
- Over 5 years (2020 to 2025), Krystal Biotech, Inc.'s common stock, shares issued (in shares) has grown at a 8.2% compound annual growth rate (CAGR), from $19.71M to $29.19M.